Using EHRs to Help Advance Drug Development and Safety Monitoring
Collectively EHRs Represent Huge Amounts of Data By Janet Woodcock, MD, Director of FDA’s Center for Drug Evaluation and Research Not long ago, electronic health records…
Read MoreCollectively EHRs Represent Huge Amounts of Data By Janet Woodcock, MD, Director of FDA’s Center for Drug Evaluation and Research Not long ago, electronic health records…
Read MoreReal-Time Data Must Simultaneously be Pushed and Pulled in the Right Ways By Brian Ahier, Director of standards and government affairs, and Ashish Shah, Chief…
Does the EHR Have Value? William A. Hyman Professor Emeritus, Biomedical Engineering Texas A&M University, w-hyman@tamu.edu Read other articles by this author On a recent…
Communicating Across Institutional Barriers By Robert Rowley, MD, co-founder and Chief Medical Officer of Flow Health Twitter: @RRowleyMD In healthcare, there has been much talk…
By Robert Rowley, MD, co-founder and Chief Medical Officer of Flow Health Twitter: @RRowleyMD As we move towards building a universal patient-centered data platform in…
Health Data is Still Siloed in the Institutions that Created Them By Robert Rowley, MD, co-founder and Chief Medical Officer of Flow Health Twitter: @RRowleyMD…
Ergonomics and Patientricity By Steve Reinecke, CLS/MT, CPHIMS, AVP Ergotron Healthcare Twitter: @ergosteve Ergotron Healthcare: @ErgoHIT Today, healthcare organizations are being challenged to provide quality care while…
FDA Posts Recall of Computerized Record System William A. Hyman Professor Emeritus, Biomedical Engineering Texas A&M University, w-hyman@tamu.edu Read other articles by this author While EHRs…
Alternative Chart-Note Capture and Other Data Input Methods Robert Rowley, MD Twitter: @RRowleyMD Some very interesting trends are occurring in the health IT arena, which…